This institution has been granted consent by the Minister of Colleges and Universities to offer this degree program for a five-year term starting June 25, 2021. Prospective students are responsible for satisfying themselves that the program and the degree will be appropriate to their needs (e.g., acceptable to potential employers, professional licensing bodies or other educational institutions). This is Canada’s only master’s degree in regulatory affairs, focused on the development and commercialization

of drugs, biologics, and medical device products. Generally speaking, the pharmaceutical and medicine manufacturing industry is not highly sensitive to changes in economic conditions—consistently experiencing growth in both jobs and profits. Because they are relied upon to get new drugs and devices tested, approved, and put on the market, regulatory affairs specialists are continually in demand. While employment prospects are bright across the field, regulatory affairs professionals with the most education are likely to enjoy the most opportunities and highest pay.